NCT00366210

Brief Summary

The purpose of this study is to compare modified CI therapy for strokes survivors with very limited function to an alternative package of conventional physical rehabilitation techniques

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Oct 2005

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2005

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 21, 2006

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
Last Updated

December 25, 2014

Status Verified

August 1, 2010

Enrollment Period

3.9 years

First QC Date

August 18, 2006

Last Update Submit

December 24, 2014

Conditions

Keywords

strokerehabilitationphysical therapyoccupational therapyarm

Outcome Measures

Primary Outcomes (1)

  • Motor Activity Log

    Pre-treatment, Post-treatment, followup

Study Arms (3)

Expanded CI therapy

EXPERIMENTAL

3.5 hours of training for the more-affected arm set in the laboratory for 15 consecutive weekdays

Behavioral: Constraint-Induced Movement (CI) Therapy

Placebo Control

PLACEBO COMPARATOR

Stretching, movement exercises, and EMG biofeedback for the same duration as the experimental intervention.

Behavioral: Stretching, Relaxation, & Biofeedback

Usual & Customary Care Control

NO INTERVENTION

Treatments available to participants as part of their regular medical care, such as conventional physical or occupational therapy. For some participants, this would involve no treatment, since all participants were more than one year post stroke.f standard clinical care.

Interventions

Expanded CI therapy

Passive stretching of both arms, EMG biofeedback for more-impaired arm

Placebo Control

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a. The ability to initiate extension against gravity at the wrist or at least one digit and initiate extension and flexion at the elbow.
  • b. No active movement required for the wrist, fingers or thumb. At least 20° active extension required at elbow.
  • \. Actively move the shoulder at least 30 degrees in flexion, abduction, or scaption 3. Score less than 4 on the Modified Ashworth Scale for all impaired joints 4. Passive range of motion criteria \> or equal to 90° shoulder flexion, \> or equal to 90° shoulder abduction, \> or equal to 45° shoulder external rotation, \< or equal to 30° short of normal elbow extension, forearm supination to at least neutral, forearm pronation 45° or more from neutral, \< equal to 35° short of normal wrist extension, and \< equal to 35° short of normal metacarpophalangeal extension on all the digits.

You may not qualify if:

  • Less than 6 months post-stroke.
  • Motor problems that are not primarily unilateral.
  • Other neurological or musculoskeletal conditions, including excessive pain, affecting UE function.
  • Insufficient stamina or serious uncontrolled medical problems.
  • Serious cognitive deficits including inadequate ability to follow test instructions.
  • Less than 19 years old. Grade 4 MMC for wrist, thumb, fingers; i.e., individuals who can actively extend the wrist \> or equal to 10°, abduct the thumb or equal to 10°, and initiate extension of at least two additional digits will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

MeSH Terms

Conditions

Stroke

Interventions

TherapeuticsBiofeedback, Psychology

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Officials

  • Gitendra Uswatte, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2006

First Posted

August 21, 2006

Study Start

October 1, 2005

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

December 25, 2014

Record last verified: 2010-08

Locations